Richmond Brothers’s Heron Therapeutics HRTX Stock Holding History

Richmond Brothers’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15M	Buy	1,436,705 +864,587	+151%	+$1M	0.77%	24
2025 Q4	$744K	Hold	572,118	–	–	0.47%	25
2025 Q3	$721K	Buy	572,118 +17,649	+3%	+$28K	0.46%	25
2025 Q2	$1.15M	Buy	554,469 +9,568	+2%	+$19.5K	0.75%	21
2025 Q1	$1.2M	Sell	544,901 -97,438	-15%	-$189K	0.76%	20
2024 Q4	$983K	Buy	642,339 +131,557	+26%	+$213K	0.63%	22
2024 Q3	$1.02M	Buy	510,782 +154,224	+43%	+$368K	0.63%	24
2024 Q2	$1.25M	Buy	356,558 +59,852	+20%	+$184K	2.47%	8
2024 Q1	$822K	Hold	296,706	–	–	1.52%	10
2023 Q4	$504K	Buy	296,706 +193,697	+188%	+$213K	0.88%	13
2023 Q3	$106K	Buy	103,009 +60,604	+143%	+$86.3K	0.2%	23
2023 Q2	$49.2K	Buy	+42,405	New	+$75.6K	0.08%	22

Other funds holding HRTX

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return